Tag results:
mesenchymal stem cells
Mesenchymal Cell News
Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells in Ischaemic Stroke (AMASCIS-02): A Phase IIb, Multicenter, Double-Blind, Placebo-Controlled Clinical Trial Protocol
[Bmj Open] Investigators developed a Phase IIb, multicentre, randomized, double-blind, placebo-controlled clinical trial protocol to evaluate the safety and efficacy of intravenous administration of allogeneic adipose tissue-derived MSCs in patients with acute ischaemic stroke, concurrently with conventional stroke treatment.
Mesenchymal Cell News
Hypoxia Preconditioned Bone Marrow-Derived Mesenchymal Stromal/Stem Cells Enhance Myoblast Fusion and Skeletal Muscle Regeneration
[Stem Cell Research & Therapy] The authors analyzed hypoxia impact on human and pig bone marrow-derived MSCs and mouse myoblast proliferation, differentiation, and fusion.
Endothelial Cell News
Engineering Vascularized Dermal Grafts by Integrating a Biomimetic Scaffold and Wharton’s Jelly MSC-Derived Endothelial Cells
[Journal of Materials Chemistry B] Scientists investigated the efficacy of endothelial cell (EC)-seeded nanofibrous scaffolds in improving vascularization in vivo. ECs derived from induced human Wharton's Jelly mesenchymal stem cells served as a potential source for cell transplantation.
Umbilical & Placental Cell News
SA/G Hydrogel Containing NRF2-Engineered HEK-293-Derived CM Improves Wound Healing Efficacy of WJ-MSCs in a Rat Model of Excision Injury
[Journal of Tissue Viability] The authors revealed that the NRF2-conditioned medium protected the wharton's jelly derived-MSCs against H2O2-induced toxicity in vitro.
Mesenchymal Cell News
Small Extracellular Vesicles from Menstrual Blood-Derived Mesenchymal Stem Cells (MenSCs) as a Novel Therapeutic Impetus in Regenerative Medicine
[Stem Cell Research & Therapy] The authors describe the basic characteristics and biological functions of menstrual blood-derived MSCs-derived small extracellular vesicles.
Mesenchymal Cell News
Transplantation of Human Autologous Synovial Mesenchymal Stem Cells with Trisomy 7 into the Knee Joint and 5 Years of Follow-Up
[Stem Cells Translational Medicine] Scientists determined the ratio of patients whose synovial MSCs were transplanted clinically, to intensively investigate MSCs with trisomy 7 from a safety perspective, and to follow up the patients for five years after transplantation.